Insiders Advisor
  • Stocks
  • World News
  • Business
  • Politics
  • Stocks
  • World News
  • Business
  • Politics

Insiders Advisor

Politics

Dr. Oz becomes next head of Medicare and Medicaid Services following approval from full Senate

by April 3, 2025
April 3, 2025
Dr. Oz becomes next head of Medicare and Medicaid Services following approval from full Senate

Dr. Mehmet Oz will serve as the next administrator of the Centers for Medicare and Medicaid Services after the full Senate voted along party lines to confirm his nomination on Thursday. 

The former daytime TV doctor turned politician will be in charge of nearly $1.5 trillion in federal healthcare spending. His duties will entail overseeing Medicare, Medicaid and the Children’s Health Insurance Program (CHIP), including directing decisions related to how the government covers procedures, hospital stays and medication, as well as the reimbursement rates at which healthcare providers get paid for their services.   

Medicare is a federal healthcare program for seniors aged 65 and up, and currently provides coverage to about 65 million Americans, according to the Center for Medicare Advocacy. Medicaid, a public health assistance program for people with low incomes, covers roughly 72 million Americans, according to Medicaid.gov. Meanwhile, CHIP, which provides free or low-cost health coverage for eligible low-income children and family members, assists around 7.2 million individuals. 

A graduate of Harvard University, Oz received medical and business degrees from the University of Pennsylvania. He is a former heart surgeon who saw his fame rise through his appearances on daytime television, including ‘The Oprah Winfrey Show,’ and 13 seasons of ‘The Dr. Oz Show.’

Oz later transitioned into politics, launching an unsuccessful bid for Pennsylvania’s open Senate seat in 2022. He lost to John Fetterman, then the state’s lieutenant governor.

‘Dr. Oz has a strong desire to modernize CMS and encourage healthy lifestyles for all Americans, including by focusing on the underlying causes of chronic disease and implementing innovative technologies,’ Senate Finance Committee Chairman Sen. Mike Crapo, R-Idaho, said Thursday.

Crapo, who led Oz’s nomination process at the committee level, commended Oz for his ‘diligence and accessibility’ throughout the process, including his willingness to answer ‘hundreds’ of questions for the record.

Those questions came from both Republicans and Democrats. They included asking about Oz’s stance on abortion, transgender medical treatments, Medicare privatization, prescription drug pricing and more. Potential financial conflicts of interest were also a concern among Democratic lawmakers throughout Oz’s confirmation process. Oz has committed to divesting any holdings that may pose an issue. 

Thursday’s confirmation comes as the Trump administration continues to work to finalize the rest of its political appointments, including notably the president’s pick to be the next United Nations ambassador and his pick for director of the Consumer Financial Protection Bureau. 

Per The Washington Post’s ‘political appointee tracker,’ there are currently still 233 nominees being considered by the Senate.

This post appeared first on FOX NEWS
previous post
Waltz’s Signal chat woes snowball as Trump admin defends national security advisor
next post
Trump confirms National Security Council firings as Waltz’s Signal chat woes snowball

Related Posts

Senate committee advances nomination of Dr Oz to...

March 25, 2025

Trump backs stock trading ban so lawmakers like...

July 31, 2025

Kennedy family members denounce RFK Jr.’s decision to...

August 25, 2024

Johnson says Trump’s Gaza takeover proposal could be...

February 5, 2025

GOP senator reveals the ‘dirty’ secret to Trump’s...

July 18, 2025

Rubio announces visa revocations on Brazilian judge for...

July 19, 2025

Ukraine to seek NATO invitation in Brussels next...

November 29, 2024

State Department confirms ‘constructive’ nuclear talks with Iran;...

May 15, 2025

Hamas refuses to attend Gaza cease-fire talks as...

August 12, 2024

The 6 biggest FBI scandals under the Biden...

January 2, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest News

    • Trump’s push for Putin-Zelenskyy talks hinges on Kremlin’s conditions

      August 19, 2025
    • Israel eliminates Gaza terrorist who took part in October attack on kibbutz, took Yarden Bibas hostage

      August 19, 2025
    • White House rejects ‘blank checks’ for Ukraine, presses NATO to shoulder costs

      August 19, 2025
    • Best Buy launches third-party marketplace as it looks for sales drivers

      August 19, 2025
    • ‘President of peace’: Trump tapped for Nobel Prize amid talks to end Russia-Ukraine war

      August 19, 2025
    • Conservative ‘playbook’ to beat Democrats in court outlined in senator’s new book

      August 19, 2025

    Categories

    • Business (1,353)
    • Politics (6,791)
    • Stocks (904)
    • World News (461)
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: insidersadvisor.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 insidersadvisor.com | All Rights Reserved